Treating advanced/metastatic urothelial carcinoma: recent developments in the BGJ398 clinical trial
What support can doctors provide patients in terms of pyschological well-being?
The use of oncolytic viruses to activate the immune system and help treat melanoma
KEYNOTE-045 – pembrolizumab as second-line treatment in urothelial carcinoma
The advantages of clinical trials
Andrea B. Apolo